Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record presents details of a completed Phase II trial of nivolumab, lenalidomide, and dexamethasone for high-risk smoldering multiple myeloma, including participant criteria, study measures, and research documents.
    Difference
    63%
    Check dated 2026-11-07T12:36:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site revision indicator updates from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:14:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and FAQs, and says NIH content may use both “Super Intelligence” and “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T12:57:13.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision marker in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:14:53.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:56:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Study record content is replaced by a 403 Forbidden error page displaying the 403 message; the header and footer remain visible, indicating access to the study details is blocked.
    Difference
    21%
    Check dated 2026-09-19T18:00:07.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.